ABC2-Funded Research Featured in Scientific American
Article | January 31, 2013
Brain cancer research funded by Accelerate Brain Cancer Cure is featured in Scientific American today.
The research involves a multi-center clinical study using new exosomal diagnostic tests developed by New York City-based Exosome Diagnostics to identify a genetic mutation found exclusively in glioma, the most common form of brain cancer.
Brain tumor cells shed micro-vesicles, called exosomes, into cerebral spinal fluid, blood, and urine. This new method of testing could potentially detect and monitor the progression of a wide variety of cancers and eliminate the need for painful and sometimes life-threatening biopsies.
Ashley Varner guest blogs about her social work pilot study on the lived experience of family members who live with someone diagnosed with a primary malignant brain tumor.
In partnership with UCSF and MD Anderson, ABC2 brought together researchers from leading medical centers and biotech companies to strategize new therapeutic paths to treat Low Grade Gliomas.
Join us in our fight for a cure!
This form needs Javascript to display, which your browser doesn't support. Sign up here instead
To sign up to receive our emails, fill in the following fields and hit submit. Thanks, and welcome!
